A novel model to predict positive prostate biopsy based on serum androgen level

  1. Norio Nonomura1
  1. 1Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  2. 2Department of Therapeutic Urologic Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  1. Correspondence should be addressed to M Uemura: uemura{at}uro.med.osaka-u.ac.jp
  1. Figure 1

    Receiver-operator characteristics (ROC) curves of the predicted probability of prostate cancer detection for all 253 patients by PSA (A), %FT (B), PSAD (C) and PSAD-%FT model (D).

  2. Figure 2

    Receiver-operator characteristics (ROC) curves of the predicted probability of prostate cancer detection by the PSAD-%FT model (solid curves) and PSA (dotted curves). (A) ROC curves for all 253 patients. (B) ROC curves for 156 patients with PSA levels under 10 ng/mL.

  3. Figure 3

    Receiver-operator characteristics (ROC) curves of the predicted probability of prostate cancer detection for 156 patients with PSA levels under 10 ng/mL by PSA (A), %FT (B), PSAD (C) and PSAD-%FT model (D).

  4. Figure 4

    Receiver-operator characteristic (ROC) curves of the predicted probability of prostate cancer detection by the PSAD-%FT model (solid curves) and PSA (dotted curves) in a testing cohort. (A) ROC curves for all 88 patients. (B) ROC curves for 59 patients with PSA levels under 10 ng/mL.

| Table of Contents
OPEN ACCESS ARTICLE